Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Stefan A. Dyckerhoff sold 7,814 shares of the business's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $107.17, for a total value of $837,426.38. Following the completion of the sale, the director now owns 121,803 shares in the company, valued at approximately $13,053,627.51. This trade represents a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Astera Labs Stock Down 1.7 %
ALAB opened at $105.48 on Wednesday. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $113.85. The business has a 50 day moving average of $72.05 and a 200-day moving average of $60.30.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million during the quarter, compared to analysts' expectations of $97.50 million. Astera Labs's revenue was up 47.1% on a year-over-year basis. Analysts forecast that Astera Labs, Inc. will post -0.45 EPS for the current year.
Analyst Ratings Changes
Free Download: Expert Trader Shares His #1 Chart Pattern For 2025
From DTI | Ad
t’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks at certain levels…
But here is the thing…
These algorithms are very predictable…
So, to claim your free digital copy today, simply follow this link and enter your email address.
A number of analysts have recently commented on ALAB shares. Citigroup started coverage on Astera Labs in a report on Monday, November 18th. They issued a "buy" rating and a $120.00 price target on the stock. Evercore ISI reduced their price target on Astera Labs from $98.00 to $80.00 and set an "outperform" rating for the company in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. Finally, Barclays increased their price target on Astera Labs from $70.00 to $87.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $94.67.
Read Our Latest Stock Analysis on ALAB
Institutional Trading of Astera Labs
A number of hedge funds have recently made changes to their positions in the business. Strategic Blueprint LLC lifted its position in shares of Astera Labs by 3.6% in the third quarter. Strategic Blueprint LLC now owns 5,684 shares of the company's stock valued at $298,000 after buying an additional 195 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Astera Labs by 5.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company's stock worth $277,000 after purchasing an additional 284 shares during the period. Hollencrest Capital Management bought a new position in shares of Astera Labs during the third quarter worth approximately $26,000. Venturi Wealth Management LLC increased its stake in shares of Astera Labs by 26.3% during the third quarter. Venturi Wealth Management LLC now owns 2,400 shares of the company's stock worth $126,000 after purchasing an additional 500 shares during the period. Finally, US Bancorp DE bought a new position in shares of Astera Labs during the third quarter worth approximately $46,000.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
